Advertisement

Risk factors and Outcomes of Emerging Listeria Monocytogenes Infection in Pakistan: Insights from a Tertiary Care Hospital

Review Article | DOI: https://doi.org/10.31579/2834-5177/047

Risk factors and Outcomes of Emerging Listeria Monocytogenes Infection in Pakistan: Insights from a Tertiary Care Hospital

  • Iffat Khanum

Dept of Medicine and Department of Pathology and Laboratory Medicine, AKUH. 

*Corresponding Author: Iffat Khanum, FCPS (IM) FCPS (ID), FRCP, MHPE Dept of Medicine and Department of Pathology and Laboratory Medicine, AKUH.

Citation: Iffat Khanum, (2025), Risk factors and Outcomes of Emerging Listeria Monocytogenes Infection in Pakistan: Insights from a Tertiary Care Hospital, International Journal of Clinical Infectious Diseases, 4(5); DOI:10.31579/2834-5177/047

Copyright: © 2025, Iffat Khanum. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Received: 08 September 2025 | Accepted: 18 September 2025 | Published: 26 September 2025

Keywords: infectious diseases; molecular diagnostics; next-generation sequencing (ngs); polymerase chain reaction (pcr

Abstract

Abstract

Listeria monocytogenes is a Gram-positive rod responsible for listeriosis. This systemic infection often presents with bacteremia and may progress to severe manifestations such as meningoencephalitis, particularly in immunocompromised individuals and the elderly. In pregnant women, it is associated with fetal and placental involvement, frequently resulting in adverse outcomes. Over the past few decades, L. monocytogenes has emerged as a significant foodborne pathogen, implicated in numerous outbreaks worldwide. The objective of this study is to assess the risk factors, clinical features, and outcomes of patients admitted with Listeria monocytogenes infection at a tertiary care Centre in Karachi, Pakistan.

Introduction

Listeria monocytogenes is a gram-positive rod, known to be an opportunistic food-borne pathogen worldwide [1].Its most common route of transmission in the community is consumption of contaminated food[2]. Listeria causes food-borne illness, can survive even in low-moisture, low temperatures usually found in refrigerators, high salt foods making it challenging to control in food environment[3].Due to its prolonged incubation period , prompt diagnosis is difficult. Numerous reports of listeriosis outbreaks have been linked to dairy products, meat products, as well as fresh produce [4]. Apart from causing non-invasive, non-fatal infections, it was discovered as a major human pathogen causing fatal illnesses, including severe meningoencephalitis and maternal-fetal infections [5].

The annual incidence rate of listeriosis varies from 0.1 to 10 cases per million people per year, depending on the countries and regions of the world [6]. Ready-to-eat dairy, seafood, and immunocompromised individuals, including pregnant women and geriatric populations, seem to be most affected by this pathogen [7-9]. Despite the low prevalence, it has a high mortality rate, particularly in high-risk populations such as neonates, pregnant females, age ≥ 60 years, primary bacteremia, CNS involvement and prior comorbidities such as malignancies, chronic kidney diseases[10]. Maternal infections with Listeria monocytogenes have been reported to be rare before 20 weeks of gestations. The incidence of listeriosis is higher among pregnant women than  in the general population and is associated with adverse fetal outcomes, including miscarriage and stillbirth[9, 11].

Treatment recommendations for listeriosis rely on knowledge gained from animal models, in vitro experiments, and clinical studies, as listeriosis is not a common disease and there aren't many effective randomized controlled trials. Ampicillin is the recommended treatment, and trimethoprim/sulphamethoxazole, meropenem can be an alternative agent in case of penicillin allergy [12]. Although penicillin and ampicillin are the recommended treatments for listeriosis, most experts advise combining gentamicin with ampicillin due to its delayed bactericidal activity against Listeria[13]. While some retrospective studies have failed to show a survival benefit— and even suggested potential harm in neurolisteriosis—other data indicate a possible survival advantage when gentamicin is administered for more than three days[14].

We aimed to identify the risk factors, clinical characteristics, and outcomes of listeriosis at a tertiary care centre, Pakistan. with the goal of understanding various clinical manifestations and predisposing conditions in our population to facilitate early recognition and management of this potentially treatable condition

Methods

A retrospective study was conducted over 7 years and included all patients with culture-proven listeriosis. Comorbid conditions, clinical presentation, treatment, and outcomes were recorded and analyzed

Results

A total of 63 patients diagnosed with Listeria monocytogenes infection were included in the study. There was female predominance (n = 44, 70.9%), with a mean age of 50.2 years. Diabetes mellitus was the most common comorbidity (43.5%). Among high-risk groups, 14 (22.6%) patients were pregnant, 10 (15.9%) were on immunosuppressive therapy, and another 10 (15.9%) were classified as elderly. The predominant presenting symptoms included fever (74.6%) and central nervous system involvement (52.0%), mainly meningoencephalitis. All patients received antibiotic therapy with either ampicillin or meropenem for a mean duration of 16.7 ± 8.4 days. The overall mortality rate was 11.1%.

Conclusion

 Listeriosis was observed not only in the elderly but also in middle-aged individuals with underlying risk factors, as well as in pregnant women. Enhanced environmental hygiene, early diagnosis, and timely treatment are essential to improving outcomes, particularly in pregnancy-related cases. Public education, healthcare provider training, and community-level preventive strategies are critical for effective management and control of listeriosis

Methodology

This retrospective, observational study was conducted from January 2017 to December 2023 at the Aga Khan University Hospital (AKUH), Karachi, Pakistan. AKUH is a Joint Commission International (JCI) accredited state-of-the-art tertiary care centre that provides care to patients from all over the country. All patients admitted with culture-proven L. monocytogenes were evaluated for possible inclusion in the study. Patients with co-infections with other bacterial infections were excluded. An extensive review of electronic and paper-based medical records, together with radiology and laboratory databases of the selected patients, was undertaken.

Pertinent information—including demographics, comorbid conditions, predisposing factors, immune status, imaging findings, management strategies, complications, and clinical outcomes—was documented on a structured proforma.

Ethical consideration

The study was reviewed and approved by the Ethics Review Committee, Aga Khan University (ERC # 2023-9294-26813). Due to the retrospective chart reviews and lack of direct involvement of patients or other human participants, a waiver of informed consent was given by the Ethics Review Committee, Aga Khan University.

Data analysis was performed using RStudio (version 4.1.2; Boston, USA). The Shapiro-Wilk test was used to assess the normality of quantitative variables, including age, premature birth, and gestational age. As all variables were found to be non-normally distributed, they were summarized using median and interquartile range (IQR). Categorical variables, such as gender, comorbidities, clinical manifestations, and patient outcomes, were summarized as frequencies and percentages. Stratified analysis was conducted based on the diagnosis Neurolisteriosis vs. Non-neurolisteriossis to explore potential statistical associations. The Mann-Whitney U test was used for continuous variables, while the Chi-square or Fisher’s exact test was applied for categorical variables, as appropriate.

Results:

A total of 63 patients met the inclusion criteria and were included in the study. The mean age of participants was 50.2 (Median 53, [Q1, Q3] [32.0, 67.0]) years, and the majority were female (n=44, 69.8%). Diabetes Mellitus (n=27, 43.5%) was the most frequent co-morbid illness, followed by hypertension (n= 25, 40.3%) and CLD (n=12, 19.0%) ( Table 1). Among the high- risk group,14 (22.6%) patients were pregnant, and 10 (15.9%) patients were on immunosuppressive therapy, and a similar percentage was classified as elderly.

The most common clinical features were fever ( n=47, 74.6%), followed by drowsiness (n=20, 31.7%), abdominal pain and vomiting (n=10, 15.9%). Nearly half (n=27, 52.0%) of the study patients presented with CNS listeriosis, predominantly meningoencephalitis, one patient had brain abscess, and 16 (25.39%) patients had concomitant bacteremia as well (Table 3).

Overall, antimicrobial susceptibility data were available for 59 cases. In three cases where Listeria monocytogenes was detected by a commercial multiplex PCR (Filmarray meningitis encephalitis panel, Biomerieux) the organism did not grow on culture. The susceptibility rates for ampicillin, meropenem and trimethoprim/sulphamethoxazole were 96.6%, 100% and 86.4% respectively.

All patients were treated with ampicillin or meropenem, depending upon the availability of drugs for 4 – 6 weeks (mean 16.7±8.4) days. The overall mortality was 11.1% and most of the patients who died were older than 60 years of age. In subgroup analysis between CNS and non-CNS listeriosis (table 4), there was no major difference found, i.e age, comorbid illness and gender distribution and mortality. Most pregnant patients had non-CNS listeriosis (p value 0.014).

Mortality was observed in 5 patients (15.2%) in CNS listeriosis and 2 patients (6.7%) in the non- CNS group. Pregnancy-related mortality was significantly higher in non-CNS involvement, with 5 patients (16.7%) compared to 2 patients (6.1%) in CNS listeriosis (p = 0.024).

Hypertension

N

Percentage

No

38

(59.7%)

Yes

25

(40.3%)

Diabetes

 

 

No

36

(56.5%)

Yes

27

(43.5%)

HIV-Status

 

 

No

62

(98.4%)

Yes

1

(1.6%)

Autoimmune disease

 

 

No

56

(88.9%)

Yes

7

(11.1%)

Malignancy

 

 

No

57

(90.5%)

Yes

6

(9.5%)

Chronic Kidney Disease

 

 

No

58

(92.1%)

Yes

6

(7.9%)

Chronic Liver Disease

 

 

No

51

(81.0%)

Yes

12

(19.0%)

Others/ Description of known disease

 

 

No

33

(52.4%)

Yes

30

(47.6%)

Immuno-compromised

 

 

No

46

(73.0%)

Yes

17

(27.0%)

On Immunosuppressive therapy

 

 

No

53

(84.1%)

Yes

10

(15.9%)

Pregnancy Status

 

 

No

30

(77.8%)

Yes

14

(22.2%)

Extreme of Age

 

 

No

53

(84.1%)

Yes

10

(15.9%)

Other

 

 

Alcoholic

2

(3.2%)

Hypothyroidism, hemolytic anemia

1

(1.6%)

Multiple myeloma

1

(1.6%)

Table 1: Listeriosis and Comorbid Conditions

 

Clinical Manifestation

Number of

Patients (n)

Percentage (%)

Diagnosis

CNS Listeria

33

52.0

Non-CNS listeria

30

48..0

Break down of CNS Listeria

Meningo-encpehalitis

26

41

Brain Abscess

1

1.58

Breakdown of Non-CNSListeria

Bacteremia

16

25.39

Colitis

2

3.17

Placental Infection

3

4.76

Non-specific diagnosis

4

6.34

Presenting Symptoms

Fever

47

74.60

Drowsiness

20

31.74

Headache

8

12.69

Seizure

7

11.11

Abdominal Pain

10

15.87

Vomiting

10

15.87

Diarrhea

4

6.34

Other nonspecific symptoms- flu,jaundice, Per rectal bleeding, dysphagia

12

19.047

PATIENTS OUTCOME

 

 

Discharged

44

69.8

Lost to follow up

11

17.5

Expired

7

11.1

Table 2: Clinical Manifestation of patients with Listeria Monocytogenes infection

 

 

Variable

CNS Listeria

Non-CNS listeria

P- value

(N=33)

(N=30)

Age (Years)

 

 

0.110

Median [Q1, Q3Max]

61.0 [35.0,68.0]48.5 [29.5, 61.5]

 

Gender

 

 

 

F

23 (69.7%)

21 (70.0%)

1.00

M

10 (30.3%)

9 (30.0%)

 

Hypertension

 

 

 

No

17 (51.5%)

21 (70.0%)

0.198

Yes

16 (48.5%)

9 (30.0%)

 

Diabetes

 

 

 

No

20 (60.6%)

16 (53.3%)

0.616

Yes

13 (39.4%)

14 (46.7%)

 

HIV Status- Affected

 

 

 

No

32 (97.0%)

30 (100%)

1.00

Yes

1 (3.0%)

0 (0%)

 

Autoimmune Disease

 

 

 

No

30 (90.9%)

26 (86.7%)

0.700

Yes

3 (9.1%)

4 (13.3%)

 

Malignancy

 

 

 

No

30 (90.9%)

27 (90.0%)

1.00

Yes

3 (9.1%)

3 (10.0%)

 

Chronic Kidney Disease

 

 

 

No

31 (93.9%)

27 (90.0%)

0.662

Yes

2 (6.1%)

3 (10.0%)

 

CLD

 

 

 

No

25 (75.8%)

26 (86.7%)

0.344

Yes

8 (24.2%)

4 (13.3%)

 

Others/ Description of known disease

 

 

 

No

17 (51.5%)

16 (53.3%)

1.00

Yes

16 (48.5%)

14 (46.7%)

 

Immuno-compromised

 

 

 

No

25 (75.8%)

21 (70.0%)

0.777

Yes

8 (24.2%)

9 (30.0%)

 

On Immunosuppressive

 

 

 

No

28 (84.8%)

25 (83.3%)

1.00

Yes

5 (15.2%)

5 (16.7%)

 

Pregnancy

 

 

 

No

13 (92.9%)

7 (35.0%)

0.001

Yes

1 (7.1%)

13 (65.0%)

 

Extreme of Age

 

 

 

No

26 (78.8%)

27 (90.0%)

0.308

Yes

7 (21.2%)

3 (10.0%)

 

Food Source

 

 

 

No

26 (78.8%)

22 (73.3%)

0.877

NOT MENTIONED

6 (18.2%)

7 (23.3%)

 

Yes

1 (3.0%)

1 (3.3%)

 

No Food Source

 

 

 

No

33 (100%)

29 (96.7%)

0.476

Yes

0 (0%)

1 (3.3%)

 

Socioeconomic status

 

 

 

High

11 (33.3%)

11 (36.7%)

0.639

Low

2 (6.1%)

0 (0%)

 

Middle

20 (60.6%)

18 (60.0%)

 

Missing

0 (0%)

1 (3.3%)

 

Other- Comorbid Conditions

 

 

 

Alcoholic

1 (3.0%)

1 (3.3%)

0.255

Multiple myeloma

1 (3.0%)

0 (0%)

 

NA

3 (9.1%)

0 (0%)

 

No

28 (84.8%)

28 (93.3%)

 

Hypothyroidism, hemolytic anaemia

0 (0%)

1 (3.3%)

 

If abortion/ premature birth, week of

pregnancy

 

 

 

Median [Q1, Q3]

30.0 [25.0, 33.5]

27.0 [24.0, 37.0]

0.970

PATIENTS OUTCOME

 

 

 

Discharged

22 (66.7%)

22 (73.3%)

0.610

Expired

5 (15.2%)

2 (6.7%)

 

Lost to follow up

6 (18.2%)

5 (16.7%)

 

PREGNANCY OUTCOME

 

 

 

EXPIRED

2 (6.1%)

5 (16.7%)

0.024

Premature delivery

1 (3.0%)

6 (20.0%)

 

Discussion

Our study showed that although listeriosis is common at extremes of age, it also significantly impacts the middle-aged population, especially those with diabetes and also pregnant females. Central nervous system (CNS) listeriosis was found to be as frequent as non-CNS cases.

Although elderly patients were not the most frequently affected group, they accounted for the majority of the deaths, with an overall mortality rate of 11%.

Listeriosis is more common among patients with prior risk factors like pregnancy, immunosuppressive state or advanced age. A higher incidence of L. monocytogenes infection has been reported among individuals over 65 years of age, likely attributed to a weakened immune response and reduced ability to combat infectious agents.[15, 16]. The median age of our study population was 53 years, with only 15.9% patients being more than 65 years of age. Yan Liu et al. also found a median age of 56 years, but with 40.7% patients aged ≥60 years.[17] . In developing countries like Pakistan, increased cases of listeriosis among patients under 65 years of age may be secondary to poor food safety, inadequate sanitation, limited public awareness, weak health infrastructure and challenges in disease surveillance, diagnosis and prevention.[18, 19]

Pakistan faces a growing burden of diabetes mellitus (DM), increasingly affecting younger individuals. [20, 21] DM impairs immune responses, predisposing patients to infections. In our study, most patients had DM, which likely explains the lower median age (<65>

Pregnant women are at increased risk of developing listeriosis than the general population, increased risk of severe disease, complications and adverse obstetric outcomes [22]. This is consistent with our study, in which 50% of pregnancies resulted in adverse outcomes, including IUD, miscarriages or neonatal death. A recent review on listeriosis during pregnancy also highlighted the significant adverse impact of Listeria infection on pregnancy outcomes, including stillbirth, intrauterine fetal demise, spontaneous abortion, neonatal listeriosis, and preterm birth [23]. This underscores the importance of educating pregnant women about preventive measures, raising awareness among healthcare professionals, including obstetricians, regarding early diagnosis and management of listeriosis during pregnancy to improve maternal and fetal outcomes.

Neurolisteriosis was also common in our study, with most patients experiencing meningitis or meningoencephalitis, and only one patient presenting with a brain abscess. The MONALISA group also reported that, among patients with neurolisteriosis, meningoencephalitis was the predominant presentation (84%), and brainstem involvement was observed in only 17%. In the subgroup analysis, no statistically significant difference was found between patients with and without CNS involvement regarding demographic characteristics, comorbidities, clinical presentations, and outcomes. CNS involvement appears to be less common among pregnant females. The incidence of neurolisteriosis reported in the literature is 30% but the occurrence of cerebral abscess secondary to monocytogenes is only 3%.[24].Our patient with listeria brain abscess was an elderly female with a history of diabetes mellitus, hypertension, non-B non-C chronic liver disease and showed complete recovery after 6 weeks of antibiotics . There is limited evidence available, primarily derived from case reports, about the management of listeria brain abscess. Prolonged antibiotic therapy (5-6 weeks) appears reasonable, with variable results of adjunctive surgical drainage. [25-27]

A recent meta-analysis reported a listeriosis-related mortality rate of approximately 23%, with most deaths occurring in individuals over 60 years of age and found that gender has no impact on mortality risk.[10]. The risk factors of mortality associated with listeriosis are neurolisteriosis, prior comorbidities like non-haematological malignancies, pulmonary diseases, chronic kidney diseases, cardiovascular diseases, malignancies, immunosuppression and multi-organ failure. [5, 10, 28].We also found high mortality among the elderly population, with no significant difference between males and females. All except one had existing comorbid illness or immunosuppressive state, but neurolisteriosis was not identified as a risk factor of mortality in the current study. This might be due to small sample size and timely management of patients presenting with neurological involvement, i.e. prompt diagnostic evaluation and early initiation of antibiotics in this high-risk group.

Our study has several limitations. It is a single-centre, retrospective study with a small sample size, and large-scale multicenter studies are required to validate our findings. It was a hospital- based study; many patients with less severe infections may have been managed in primary health centres and might not have presented to tertiary care hospitals, potentially leading to underrepresentation of milder cases. Additionally, retrospective design may have resulted in incomplete documentation with missing information on predisposing factors such as dietary history and environmental exposures.

Conclusion

Listeriosis significantly affects not only the elderly but also middle-aged individuals, particularly those with underlying risk factors and during pregnancy. Environmental hygiene, early diagnosis, and prompt treatment are crucial to reducing adverse outcomes, especially in pregnancy-related cases. Raising public awareness, educating healthcare workers for early diagnosis and management, and implementing preventive measures at the community level can greatly improve listeriosis outcomes.

 

Acknowledgements: None

Funding: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

References

Clinical Trials and Clinical Research: I am delighted to provide a testimonial for the peer review process, support from the editorial office, and the exceptional quality of the journal for my article entitled “Effect of Traditional Moxibustion in Assisting the Rehabilitation of Stroke Patients.” The peer review process for my article was rigorous and thorough, ensuring that only high-quality research is published in the journal. The reviewers provided valuable feedback and constructive criticism that greatly improved the clarity and scientific rigor of my study. Their expertise and attention to detail helped me refine my research methodology and strengthen the overall impact of my findings. I would also like to express my gratitude for the exceptional support I received from the editorial office throughout the publication process. The editorial team was prompt, professional, and highly responsive to all my queries and concerns. Their guidance and assistance were instrumental in navigating the submission and revision process, making it a seamless and efficient experience. Furthermore, I am impressed by the outstanding quality of the journal itself. The journal’s commitment to publishing cutting-edge research in the field of stroke rehabilitation is evident in the diverse range of articles it features. The journal consistently upholds rigorous scientific standards, ensuring that only the most impactful and innovative studies are published. This commitment to excellence has undoubtedly contributed to the journal’s reputation as a leading platform for stroke rehabilitation research. In conclusion, I am extremely satisfied with the peer review process, the support from the editorial office, and the overall quality of the journal for my article. I wholeheartedly recommend this journal to researchers and clinicians interested in stroke rehabilitation and related fields. The journal’s dedication to scientific rigor, coupled with the exceptional support provided by the editorial office, makes it an invaluable platform for disseminating research and advancing the field.

img

Dr Shiming Tang

Clinical Reviews and Case Reports, The comment form the peer-review were satisfactory. I will cements on the quality of the journal when I receive my hardback copy

img

Hameed khan